Cargando…
Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344438/ https://www.ncbi.nlm.nih.gov/pubmed/34471526 http://dx.doi.org/10.1093/ckj/sfab102 |
| _version_ | 1783734474423402496 |
|---|---|
| author | Demoulin, Nathalie Scohy, Anaïs Gillion, Valentine Godefroid, Nathalie Jadoul, Michel Morelle, Johann |
| author_facet | Demoulin, Nathalie Scohy, Anaïs Gillion, Valentine Godefroid, Nathalie Jadoul, Michel Morelle, Johann |
| author_sort | Demoulin, Nathalie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8344438 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83444382021-08-10 Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab Demoulin, Nathalie Scohy, Anaïs Gillion, Valentine Godefroid, Nathalie Jadoul, Michel Morelle, Johann Clin Kidney J Letters to the Editor Oxford University Press 2021-06-11 /pmc/articles/PMC8344438/ /pubmed/34471526 http://dx.doi.org/10.1093/ckj/sfab102 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letters to the Editor Demoulin, Nathalie Scohy, Anaïs Gillion, Valentine Godefroid, Nathalie Jadoul, Michel Morelle, Johann Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab |
| title | Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab |
| title_full | Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab |
| title_fullStr | Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab |
| title_full_unstemmed | Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab |
| title_short | Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab |
| title_sort | low rates of humoral response to bnt162b2 sars-cov-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344438/ https://www.ncbi.nlm.nih.gov/pubmed/34471526 http://dx.doi.org/10.1093/ckj/sfab102 |
| work_keys_str_mv | AT demoulinnathalie lowratesofhumoralresponsetobnt162b2sarscov2vaccinationinpatientswithimmunemediatedkidneydiseasestreatedwithrituximab AT scohyanais lowratesofhumoralresponsetobnt162b2sarscov2vaccinationinpatientswithimmunemediatedkidneydiseasestreatedwithrituximab AT gillionvalentine lowratesofhumoralresponsetobnt162b2sarscov2vaccinationinpatientswithimmunemediatedkidneydiseasestreatedwithrituximab AT godefroidnathalie lowratesofhumoralresponsetobnt162b2sarscov2vaccinationinpatientswithimmunemediatedkidneydiseasestreatedwithrituximab AT jadoulmichel lowratesofhumoralresponsetobnt162b2sarscov2vaccinationinpatientswithimmunemediatedkidneydiseasestreatedwithrituximab AT morellejohann lowratesofhumoralresponsetobnt162b2sarscov2vaccinationinpatientswithimmunemediatedkidneydiseasestreatedwithrituximab |